Login / Signup

Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.

B Fredrik LindbergIda NelsonJonas RanstamDonald K Riker
Published in: PloS one (2023)
The safety and tolerability of ColdZyme have been confirmed in a large study population and further establishes evidence of a faster recovery from common cold symptoms. Early self-diagnosis and early use of ColdZyme mouth spray is a safe alternative for treatment of naturally occurring colds.
Keyphrases
  • double blind
  • randomized controlled trial
  • placebo controlled
  • open label
  • study protocol
  • combination therapy
  • phase iii